in investment Securities 5. Investments in subsidiary and affiliated 6. Receivables from Clearing House 7. Securities business receivables and Derivatives business receivables 8. Others derivatives
repurchase agreement 4. Investments in investment Securities 5. Investments in subsidiary and affiliated 6. Receivables from Clearing House 7. Securities business receivables and Derivatives business
reverse repurchase agreement 4. Investments in investment Securities 5. Investments in subsidiary and affiliated 6. Receivables from Clearing House 7. Securities business receivables and Derivatives
administrative expenses came from the transfer of business of Fancy Wood International Company Limited (subsidiary) From the abovementioned reasons had caused the consolidated financial statements of the Company
will meet the demand of the customers, which will increase Company’s competitiveness and continuously maintain growth rate of the Company. (9) Source of Funds : The Subsidiary will use its term loans and
of Shareholders No.1/2019 On March 18, 2019, the Extraordinary General Meeting of Shareholders approved the Company and the subsidiary to settle the disputes with the Expressway Authority of Thailand
0.5 million Baht, whereby its performance may gradually improve. It is due to the subsidiary has received approval from the shareholders to increase the capital, according to the shareholding proportion
change in status of associate to subsidiary and other income from the collection from receivables 5.43 million baht. Separate financial statements Revenues 1. Revenues from Sales 5.07 Million Baht increase
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share